Invibio, Inc., a leading innovator in the biomaterials industry, is headquartered in the United States and operates extensively across global markets. Founded in 2001, the company has established itself as a pioneer in the development of advanced polymer solutions, particularly for the medical device sector. Invibio's core offerings include PEEK (polyether ether ketone) biomaterials, renowned for their exceptional strength, biocompatibility, and versatility. These unique properties make Invibio's products ideal for a range of applications, from orthopaedics to spinal implants. With a strong market position, Invibio has achieved significant milestones, including collaborations with major medical device manufacturers and contributions to groundbreaking surgical technologies. The company continues to drive innovation, setting industry standards in performance and safety.
How does Invibio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Invibio, Inc.'s score of 68 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Invibio, Inc., headquartered in the US, currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Victrex plc, which cascades its climate commitments and initiatives down to Invibio. Victrex plc has set ambitious targets for carbon reduction, which include commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to align corporate strategies with climate science and enhance transparency regarding emissions. While Invibio does not have its own documented reduction targets, it benefits from the overarching climate strategies of Victrex plc, which are designed to mitigate environmental impact and promote sustainability across its operations. As part of the corporate family, Invibio is expected to adhere to the climate commitments established by Victrex, contributing to a collective effort towards reducing carbon footprints and addressing climate change.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 21,203,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 17,932,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 3,839,000 | 0,000,000 | 0,000,000 | - | 00,000,000 | - | - | - | 00,000,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Invibio, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.